维普期刊资源整合服务平台（V6.5）

33篇 您的检索式：作者名="Astermark"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Prophylactic treatment for severe haemophilia:comparison of an intermediate-dose to a high-dose regimen显示文摘	Fischer K Astermark J van der Bom JG	2002	Haemophilia2002，8，6：	1
2	Polymorphisms in the IL10 but not in the ILl beta and IL4 genes are associated with inhibitor development in patients with hemophilia 显示文摘	ASTERMARK J OLDENBURG J PAVLOVA A	2006	Blood2006，107，8：	1
3	The Malmo International Brother Study (MIBS) : further support for genetic predisposition to inhibitor development in hemophilia patients显示文摘	ASTERMARK J BERNTORP E WHITE GC	2001	Haemophilia2001，7，3：	1
4	Consensus perspectives on prophylactic therapy for haemophilia: summary statement显示文摘	Berntorp E Astermark J Bjorkman S	2003	Haemophilia2003，9，1：	1
5	Primary proph- ylaxis in severe haemophilia should be started at an early age but can he individualized显示文摘	Astermark J Petrini P Tengborn L	1999	Br J Haematol1999，105，4：	1
6	Prophylac- tic treatment for severe haemophilia:comparison of an in- termediate-dose to a high-dose regimen显示文摘	Fischer K Astermark J van der Bom JG	2002	Haemophilia2002，8，6：	1
7	Current use of by-passing agents in Europe in the management of acute bleeds in patients with haemophilia and inhibitors 显示文摘	ASTERMARK J ROCINO A Von DEPKA M	2007	Haemophilia2007，13，1：	1
8	The Malmn International Brother Study ( MIBS ) : further support for genetic predisposition to inhibitor development in hemophilia patients显示文摘	Astermark J Berntorp E White GC	2001	Haemophilia2001，7，：	1
9	Low recurrence rate after deep calf-vein thrombosis with six weeks of oral anticoagulation显示文摘	Astermark J Bjorgell O Linden E	1998	Journal of Internal Medicine1998，244，：	1
10	Prophylactic treatment for severe haemophilia:comparison of an intermediate-dose to a high-dose regimen显示文摘	Fischer K Astermark J van der Bom J G		0，，6：	1
11	Daily dosing prophylaxis for haemophilia:a randomized crossover pilot study evaluating feasibility and efficacy显示文摘	Lindvall K Astermark J Bjorkman S	2012	Haemophilia2012，18，6：	1
12	Prophylactic treatment for severe haemophilia: comparison of an intermediatedose to a high- dose regimen显示文摘	Fischer K Astermark J van der Bom JG	2002	Haemophilia2002，8，：	1
13	Prophylactic treatment for severe haemophilia:comparison of an intermediate-dose to a high-dose regimen显示文摘	Fischer K Astermark J van der Bom J G		0，，6：	1
14	The polygenic nature of inhibitors in hemophilia A: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort显示文摘	Astermark J Donfield SM Gomperts ED	2013	Blood2013，121，：	1
15	Non-genetic risk factorsand the development of inhibitors in haemophilia:a comprehensivereview and consensus report显示文摘	Astermark J Altisent C Batorova A	2010	Haemophilia2010，16，5：	1
16	Why do inhibitors develop? Principles of and factors influencing the risk for inhibitor development in haemophilia显示文摘	Astermark J	2006	Haemophilia2006，12，3：	1
17	Inhibitor development 显示文摘	Astermark J Lacroix-Desmazes S Reding M T	2008	Haemophilia2008，14，3：	1
18	Primary prophylaxis in severe haemophilia should be started at an early age but can be individualized显示文摘	Astermark J Petrini P Tengborn L	1999	Br J Haematol1999，105，6：	1
19	PROPHYLACTIC TREATMENT FOR SEVERE HAEMO-PHILIA : COMPArison of an intermediate- dose to a high-dose regimen显示文摘	FISCHER K ASTERMARK J VAN DER BOM JG ET AL	2002	Haemophilia2002，8，6：	1
20	Anti- and procoagulant activities in factor Ⅶ-deficient subjects 显示文摘	Tengborn L Hedner U	2001	Thromb Res2001，101，6：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示